Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis
BackgroundNeuropilin (NRP) is a transmembrane protein, which has been shown to be a pro-angiogenic mediator and implicated as a potential driver of cancer progression. NRP-1 up-regulation in ovarian cancer tissue predicts poor prognosis. However, the clinical relevance of the soluble form of NRP-1 (...
Main Authors: | Daniel Martin Klotz, Jan Dominik Kuhlmann, Theresa Link, Maren Goeckenjan, Lorenz C. Hofbauer, Andy Göbel, Tilman D. Rachner, Pauline Wimberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.974885/full |
Similar Items
-
Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients
by: Andy Göbel, et al.
Published: (2019-06-01) -
The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone
by: Andy Göbel, et al.
Published: (2021-05-01) -
Life-time experience of violence as a risk factor for symptomatic endometriosis
by: Maren Goeckenjan, et al.
Published: (2023-12-01) -
Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity
by: Lila Bemmerlein, et al.
Published: (2022-01-01) -
<i>FNTB</i> Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer
by: Hagen Sjard Bachmann, et al.
Published: (2022-01-01)